Cross-linking of Plasmodium falciparum Liver Stage Antigen-1 by Tissue Transglutaminase
Author Information
Author(s): William S. Nicoll, John B. Sacci, Carlo Rodolfo, Giuseppina Di Giacomo, Mauro Piacentini, Zoe J. M. Holland, Christian Doerig, Michael R. Hollingdale, David E. Lanar
Primary Institution: U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research
Hypothesis
Does tissue transglutaminase cross-link Liver Stage Antigen-1 in Plasmodium falciparum?
Conclusion
The study suggests that LSA-1 becomes highly cross-linked, which may help protect the parasite during its development.
Supporting Evidence
- LSA-1 is a protein produced by malaria parasites during their development in the liver.
- Tissue transglutaminase can modify proteins by forming unique cross-links.
- The study demonstrated that LSA-1 is cross-linked in infected human hepatocytes.
Takeaway
This study found that a protein from malaria parasites sticks together in a special way, which might help the parasites survive in the liver.
Methodology
The study used recombinant proteins and in vitro assays to test for cross-linking by tissue transglutaminase.
Limitations
The study could not purify native LSA-1 due to low infection rates in the chimeric mouse model.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website